EchoSolv AS vs CAC Software
AI Verdict
Choose EchoSolv AS if…
Choose EchoSolv AS if your primary goal is to accurately and efficiently identify patients at high risk for severe aortic stenosis using existing echocardiogram measurements. This tool is ideal for cardiology departments seeking AI-powered clinical decision support to prioritize studies for closer review and enhance the consistency of severe AS probability assessments within their current PACS workflow.
View EchoSolv AS →Choose CAC Software if…
Choose CAC Software if you need to automate the quantification of coronary artery calcification from non-contrast chest CT scans to support coronary artery disease risk assessment. This solution is best suited for radiologists and cardiologists looking for detailed outputs like Agatston scores, arterial age, and 3D visualizations to enhance their diagnostic capabilities and integrate seamlessly into DICOM viewing workflows.
View CAC Software →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | EchoSolv AS | CAC Software |
|---|---|---|
| Deployment | Cloud-based | Cloud-based (SaaS), integrates with PACS |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
EchoSolv ASEchoSolv AS emphasizes ultra-fast risk detection (under 3 seconds) and is designed to fit existing workflows without requiring EMR integration, simplifying deployment and user adoption. Its measurement-based AI approach also contributes to a potentially lower-friction integration and use experience.
Clinical Value
EchoSolv ASBoth tools are FDA-cleared and offer significant clinical value. However, EchoSolv AS has demonstrated near-perfect accuracy in detecting severe aortic stenosis, outperforming traditional clinical interpretation and improving diagnostic equity, particularly in challenging cases like those involving women and low-gradient presentations. This direct impact on reducing missed diagnoses for a life-threatening condition provides a stronger clinical value proposition.
Pricing & Value
EchoSolv ASWhile both require direct contact for specific pricing, EchoSolv AS has publicly outlined its subscription-based model and identified a reimbursement pathway with estimated rates (US$100-US$150 per use), offering more transparency and a clearer understanding of its economic value proposition for potential users.
Enterprise Readiness
CAC SoftwareTool B, Imbio's CAC Software, offers greater deployment flexibility with options for cloud, on-premise, and integration through partner platforms. This caters to a wider range of enterprise IT infrastructures and security preferences, making it potentially more adaptable for diverse healthcare organizations.
Innovation
EchoSolv ASEchoSolv AS employs a unique 'measurement-based AI' that deliberately avoids LVOT measurements to infer severe AS from peripheral signs, a novel approach to enhance robustness and real-world readiness. Its training on the world's largest echo-linked mortality database and use of a mixture density network for probabilistic risk prediction also highlight a distinct innovative edge.
Support & Docs
CAC SoftwareImbio's CAC Software provides explicit details on its support channels, including phone and email, specified operating hours (8:00 AM u2013 6:00 PM CST), and international contact information. This indicates a more comprehensive and readily accessible support infrastructure compared to EchoSolv AS, which primarily mentions a clinician user manual and reimbursement documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | EchoSolv AS | CAC Software |
|---|---|---|
| Name | EchoSolv AS | CAC Software |
| Company | Echo IQ | Imbio |
| Primary Use Case | Identify patients at risk for severe aortic stenosis | Determine location and calculate amount of calcification within coronary arteries |
| Input Data Type | Echocardiogram measurements (numerical measurements) | Non-contrast, chest computed tomography (CT) images |
| Key Output/Metrics | Severe AS probability, guideline check, second reader support | Agatston score, arterial age, calcified lesion mass and volume, 3D visualizations, annotated images |
| Integration Method | Fits existing workflows, integrates with PACS (no EMR integration required) | Integrates into existing DICOM viewing workflow |
Videos
Demos, reviews, and walkthroughs featuring EchoSolv AS and CAC Software.